PROPOSED RULEMAKING
STATE BOARD OF MEDICINE
[49 PA. CODE CHS. 16 AND 18]
Physician Assistants
[35 Pa.B. 6127] The State Board of Medicine (Board) proposes to amend §§ 16.11 and 16.13 (relating to licenses, certificates and registrations; and licensure, certification examination and registration fees) and §§ 18.121, 18.122, 18.131, 18.141--18.145, 18.151--18.159, 18.161, 18.162, 18.171, 18.172 and 18.181 pertaining to physician assistants (PA) and their supervising physicians to read as set forth in Annex A.
A. Effective Date
The proposed rulemaking will be effective upon final-form publication in the Pennsylvania Bulletin.
B. Statutory Authority
Section 13 of the Medical Practice Act of 1985 (act) (63 P. S. § 422.13) authorizes the Board to promulgate regulations that define the services and circumstances under which a PA may perform a medical service and which define the supervision and personal direction required by the standards of acceptable medical practice embraced by the medical doctor community in this Commonwealth.
C. Background and Purpose
Since the PA regulations were last amended in 1993, experience in the application of the regulations has demonstrated the need for amendments that reflect the current state-of-the-art of medical practice as can also be observed in the American Medical Association (AMA) guidelines for PAs. The existing regulations prevent the effective use of PAs to the full extent of their training. The Board notified the regulated community that it intended to propose updating its PA regulations and sought predraft input. Numerous medical doctors and physician organizations wrote to support the proposed amendments, noting that the current regulations are, in many ways, overly and unnecessarily restrictive.
D. Description of the Proposed Rulemaking
There are extensive revisions proposed to these regulations. Some of the amendments are in the nature of editorial changes, mostly to conform the regulatory language to the 2002 amendments to the act. Other changes are more substantive in nature.
The following is a section-by-section summary of the proposed rulemaking by category.
The proposed rulemaking amends the term ''physician assistant supervisor'' to ''supervising physician'' in § 18.121 (relating to purpose) and at all other places it appears in Chapters 16 and 18. The amendment emphasizes that the PA's supervisor must be a physician and eliminates the confusion that sometimes surrounded the term ''physician assistant supervisor.''
Proposed § 18.122 (relating to definitions) would delete the definition of ''direct supervision.'' The term ''direct supervision'' is found only in § 18.162 (relating to emergency medical services), which the Board proposes to amend by deleting the requirement that PAs provide emergency services only under the direct supervision of the supervising physician.
The definition of ''supervision'' would also be amended to more accurately reflect how PAs are actually supervised and more clearly reflect the important responsibility that the PA assumes when serving in this role. The amendments primarily ease the need for the physical presence and intervention of the physician in oversight of the PA. The amended definition reiterates that the constant physical presence of the supervising physician is not required so long as the supervising physician and PA are or can easily be in contact with one another by radio, telephone or other telecommunication device.
Under examples of the ''appropriate degree of supervision,'' § 18.122(iii) would be amended to eliminate the requirement for weekly review of patient charts. The proposed amendment more closely aligns with the practicality of a physician's practice. Current requirements of chart review and counter-signature of all PA charts are cumbersome and ineffective. A review of selected charts which have specific diagnoses or complex medical management would support a more effective use of physician time and promote quality assurance.
The definition of ''medical regimen'' would be changed to a therapeutic, corrective or diagnostic measure undertaken or ordered by a physician or PA acting within the PA's scope of practice and in accordance with the written practice agreement between the supervising physician and the PA. Currently, the text reads that a medical regimen is ordered only by the supervising physician which is for the management of a specific condition and which is incorporated into the written agreement between the supervising physician and PA.
The proposed amendments would define ''order'' as ''an oral or written directive for a therapeutic, corrective or diagnostic measure, including a drug to be dispensed for onsite administration in a hospital, medical care facility or office setting.'' This new language would provide clarity as to the parameters of an order and provide a comprehensive foundation which lends itself to the expanded definition of a medical regime.
Proposed amendments to § 18.131 (relating to recognized educational programs) would change approval of PA training programs to recognition of those programs to more accurately reflect that the Board does not approve programs but rather recognizes those that are accredited, as mandated by section 36(b) of the act (§ 422.36(b).
This proposed rulemaking updates the reference to the training program approvals for PAs by the AMA's Committee on Allied Health Education and Accreditation (CAHEA), Commission for Accreditation of Allied Health Educational Programs (CAAHEP), Accreditation Review Commission (ARC-PA) or any successor organization. In 1994, the AMA made CAHEA, its accreditation body, independent and changed its name to CAAHEP. In 2000, ARC-PA was created due to the overwhelming growth of PA programs and the difficulties that developed in trying to evaluate them appropriately. The AMA and other physician groups remain active in the accreditation process and occupy seats on the committee.
Section 18.142(a)(2) (relating to written agreements) would be amended so the written agreement will no longer be specific as to the requirement for describing how the PA will assist each physician. The section would be amended to state that the agreement list functions that will be delegated to the PA, deleting the requirements that it also describe how the PA will assist each named physician and the details of how the supervising physician will be assisted. The amendments would also have the agreement signed only by each physician acting as a supervising physician or a substitute supervising physician instead of by each physician and the PA. It would also describe how the PA ''works with'' instead of ''assists'' each physician. Currently, the regulations specify that the agreement contain procedures selected from the list in § 18.151 (relating to role of physician assistant), all other delegated tasks, instructions for use of the PA in the performance of delegated tasks and medical regimens to be administered or relayed by the PA. This requirement inhibits the effective utilization of PAs. In addition, it forces the Board to become more directly involved in the approval of practice guidelines for physicians and PAs rather than credentialing health care professionals.
Proposed amendments to §§ 18.144 and 18.155 (relating to responsibility of primary physician assistant supervisor; and satellite locations) eliminate the requirement for the supervising physician to see each patient on every third visit or at least once a year. The Board proposes in § 18.44(4) to require that the physician determine the need to see each patient based upon the patient's individual needs or at the patient's request. The amendment recognizes that the involvement of the supervising physician should be predicated on factors such as the practice type, site and the condition of the patient. This would also apply to satellite facilities. Because the existing requirement applies to all patients who are treated by a PA it includes within its application situations in which it is virtually impossible for a physician to meet. For example, if a patient is seen by a PA for a minor problem and does not return within a year to be seen by the physician, the physician cannot comply with the requirement. Attempts to meet the requirements of the existing regulation result in inefficient use of resources. The PA can easily manage a patient with a well-controlled chronic problem who is checked periodically to see if all is well. However, if the patient is checked only once annually, a physician must be involved due to the requirements of the existing regulation. Experience has demonstrated that the existing regulation is counter-productive. The option remains for the patient to request to be seen by the supervising physician.
The Board also proposes to amend § 18.151. This section currently includes a list of tasks that the PA can perform (subject to the proviso that the list is not all-inclusive). The list of tasks PAs can perform in the current regulations is somewhat limiting. Although the regulation states that the list is not intended to be all-inclusive, the Board is prohibited by court rulings from rendering advisory opinions. Therefore, one is left to speculate as to whether or not a given task not on the list, but critical to a particular practice, is permitted. The proposed rulemaking would replace the list with statements that the PA may practice medicine with physician supervision and perform duties as delegated by the physician. As amended, this section would establish as a baseline standard that the PA should be authorized to perform any medical service delegated by the physician.
Currently, § 18.152 (relating to prohibitions) prohibits a PA from pronouncing death. The amendments proposed to §§ 18.151 and 18.152 would allow a PA to pronounce a patient dead and also allow a PA to authenticate with his signature any form related to pronouncing death. PAs who practice in long term care facilities, hospital wards, hospice care or in hematology/oncology, among other specialties, encounter circumstances when they may be the only medical care provider available at the time of a patient's death. Allowing delegation of the pronouncement of death simplifies procedures for the patient's family at a difficult time. The amendment allows only pronouncement of death. Certification as to the cause of death continues to be reserved for the supervising physician or a coroner as set forth in section 502 of the Vital Statistics Law of 1953 (35 P. S. § 450.502).
Amended § 18.151 would also allow the PA to sign any form that otherwise requires a physician's signature as permitted by the supervising physician, state or Federal law and facility protocol, if applicable. This will relieve the physician of much routine paperwork such as signing forms for school physicals.
Among the list of those things in § 18.152 that a PA may not do is the performance of a medical service without physician supervision as set forth in the written agreement.
The proposed amendments to § 18.153 (relating to executing and relaying medical regimens) change the 12-hour requirement for the PA to relate all medical regimens executed or relayed while the physician was not present to the supervising physician to 36 hours. This is also reflected in § 18.158 (relating to prescribing and dispensing drugs) for all medications prescribed or dispensed and is applicable to prescribing or dispensing ''in accordance with the written agreement.'' The 12-hour time frame in both aspects of the current regulations proved to be overly restrictive. It is not uncommon that a treatment for a minor illness done late in the day goes unreported until the start of the next business day, more than 12 hours later. For PAs taking weekend call, the reporting for minor problems would not occur until the following Monday.
The Board proposes to amend § 18.153(b) by extending the period for reporting to the supervising physician from 12 to 36 hours in § 18.155(b)(4) and the outside period for countersignature from 3 to 10 days as in § 18.153(c). For satellite facilities, the proposed amendments would also lengthen the time for counter-signature to 10 days. During predraft input, the medical doctor community advised the Board that the current 3-day counter-signature requirement is too restrictive and causes compliance problems. The regulation does not take into consideration weekends or a supervising physician's vacation schedules. This is particularly troublesome for satellite facilities. By expanding to a 10-day signature, compliance becomes more practical. This amendment is also incorporated into §§ 18.142 and 18.158.
Current § 18.157 (relating to administration of controlled substances and whole blood and blood components) provides that a PA may administer controlled substances as well as whole blood and blood components if that authority is addressed in the written agreement and is separately ordered by the supervising physician specifying a named drug for a named patient. The Board proposes to eliminate the requirement for the separate order of the supervising physician specifying the drug and patient and allowing it to be addressed only in the written agreement and be administered by the PA on that authority. The Board believes that the current language creates an unnecessary barrier to utilization of PAs in surgical, hematology/oncology, pain management and hospice care.
Section 18.158 currently includes a formulary of categories of drugs that a PA may prescribe if permission is granted in the written agreement. The supervising physician reviews this formulary and chooses those categories of drugs that he will allow the PA to prescribe or dispense. The list becomes a part of the written agreement that must be submitted to the Board. The amendment would eliminate the formulary. Instead, new subsections (a) and (b) state that the physician can delegate prescribing, dispensing and administration of drugs and therapeutic devices to the PA if the drug or device is permitted under the written agreement. The PA would be subject to the regulations of the Board and the Department of Health regarding dispensing standards, prescribing and labeling. The proposed rulemaking would have the written agreement only contain a list of categories of drugs that the PA may not prescribe. The existing formulary suffers from the same limitations noted with the list of tasks a PA can perform. The current formulary is out-of-date and places restrictions on common drugs used to treat patient problems routinely managed by PAs. For example, the management of warfarin sodium therapy for atrial fibrillation, deep venous thrombosis and mechanical heart valves has become commonplace in the family practice setting. PAs are routinely called upon to adjust medication levels. The proposed rulemaking would delete current restrictions on prescribing of blood formation or coagulation drugs.
Currently, § 18.158(a)(4) creates a 90-day waiting period after approval by the Food and Drug Administration (FDA) for a new drug or new uses for a drug before a PA can prescribe it. The proposed rulemaking eliminates that waiting period. The original purpose has been overcome by practice in recent years. Because physicians provide ongoing input and oversight in the treatment of patients by the PAs, delaying the prescribing for 90 days is overly restrictive.
The proposed rulemaking also deletes a statement in § 18.158(b)(4) specifying that the supervising physician assumes responsibility for all prescriptions and dispensing of drugs by the PA. However, § 18.144 requires the supervising physician to assume responsibility for the performance of the PA, so this amendment is editorial in that it simply eliminates redundancy.
The proposed rulemaking deletes subsection (g), which states that the PA may only prescribe or dispense drugs for a patient under the care of the supervising physician. PAs often provide care to patients in a practice that are new patients or regularly see one of the primary supervisor's partners. This section is also redundant and limiting because the supervising physician assumes ultimate responsibility for every patient seen by the PA as set forth in § 18.402(a)(6) (relating to delegation) and section 17(c) of the act (63 P. S. § 422.17(a)).
The Board proposes to delete a prohibition in § 18.158(c)(4)(i) preventing a PA from prescribing or dispensing a pure form or combination of drugs. The Board finds the prohibition is vague and unnecessary due to the current state of training received by PAs. Predraft input suggested that experience has demonstrated that PAs have the knowledge and skill to properly perform this function.
The amendments in § 18.158(c)(4)(iii) and (iv) eliminate the statement in that a PA may not prescribe or dispense drugs not approved by the FDA. Existing law already prevents anyone, including physicians, from prescribing or dispensing drugs not approved by the FDA.
The proposed rulemaking removes from § 18.158 (c)(4)(v) the prohibition on a PA prescribing or dispensing parenteral drugs other than insulin or emergency allergy kits or other approved drugs. Comments provided in pre-draft input advised that this regulation is overly restrictive.
Section 18.158(c)(4)(viii) currently states that a PA may not issue a prescription for more than a 30-day supply of medication except in cases of chronic illness where the PA can write for a 90-day supply. It also states that the PA can authorize refills up to 6 months from the original prescription. This proposed rulemaking seeks to eliminate these limitations. The existing limitation proved too restrictive. For example, it is not unusual to prescribe contraceptives for a year for healthy individuals or prescribe medications for the management of stable chronic conditions. The existing limitations can cause patients to incur additional costs for unnecessary office visits in order to continue receiving the medication.
Section 18.158(a)(5) is amended to add a provision authorizing the PA to receive, sign for and distribute drug samples. This provision will allow the PA to relieve the supervising physician of this duty and allow the PA to dispense samples of medications he is already authorized to dispense.
In addition, proposed § 18.158(a)(6) specifically mentions that the PA who will prescribe controlled substances must register with the Federal Drug Enforcement Administration (DEA). Proposed § 18.158(b)(2) also specifies that space on prescription blanks must be provided for the PA to record his DEA number. This amendment reminds the PA of the requirement to register and serves to bring the PA's practice into conformance with Federal law.
The current regulations do not allow PAs to prescribe or dispense Schedule I or II controlled drugs. Proposed § 18.158(a)(3) calls for allowing them to prescribe or dispense Schedule II controlled drugs for initial therapy up to a 72-hour dose and requires that they notify the supervising physician within 24 hours. It would also allow the PA to write a prescription for a Schedule II controlled drug for up to a 30-day supply if originally ordered and approved for ongoing therapy by the supervising physician. There are many physician and PA specialties that deal with chronic pain management. In specialties such as oncology, surgery, anesthesiology or in the family practice setting, PAs are an integral part of patient care. Managing the patients' pain in these settings often requires the ability to write prescriptions for Schedule II narcotics on both a short and long-term basis. At times, patients may require therapy or need to renew prescriptions when the physician is not immediately available but his PA is available. Also, there are many PAs that work in settings such as emergency rooms, walk-in clinics and industrial clinics. The inability to write a prescription for a Schedule II narcotic impedes the care of the patient in these settings. Allowing for a 72-hour supply of medicine until a physician sees that patient enhances the care rendered by the PA.
Current § 18.158(c)(4)(iii) does not allow PAs to prescribe medications for uses not approved by the FDA. This proposed rulemaking would no longer prohibit this ''off-label'' prescribing, but instead mandates that the PA follow the supervising physician's instructions and the written agreement. The FDA approves uses of medications for the purpose of marketing by the manufacturer, not for use by physicians. Off-label use may represent the best standard of care. The decision to use a medication for this purpose should be left to the clinician. The best example of an off-label use of a drug is the millions of prescriptions for aspirin after myocardial infarction. Off-label use of drugs is common in areas such as AIDS-related treatment, oncology and pediatrics. In pediatrics, as many as 80% of drugs are administered off-label because manufacturers are understandably reluctant to enroll young children in clinical trials of many drugs.
The amendments to § 18.158 also would delete the prohibition against a PA compounding ingredients when dispensing drugs except for adding water in paragraph (4)(vii). There are several medication mixtures that are commonly used in practice. One is the mixture of Benadryl, viscous Lidocaine and Maalox in the treatment of stomatitis secondary to chemotherapy. Pediatric groups will typically combine decongestants and cough suppressants in other doses than commercially available.
Section 18.161(b) (relating to physician assistant employed by medical care facilities) currently calls for the PA to only be responsible to a maximum of three supervising physicians. The proposed amendment to § 18.161 allows supervising physicians to make that determination by deleting this requirement. Health professional regulations should allow for flexible and creative innovation and appropriate use of all members of the health care workforce. Medical facilities should be allowed some flexibility in staffing and team deployment so long as they maintain proper supervisory arrangements. The current regulation restricts the ability of the PA to serve as house staff in a medical care facility for more than three physicians. This is particularly true in the surgical subspecialty setting. PAs may rotate as frequently as every month to different surgical subspecialties and be responsible to multiple surgeons in the process. The current regulations restrict this ability.
This proposed rulemaking adds § 18.162(b) to address the practice of PAs in emergency situations. The emergency situations addressed are those in a disaster situation and not in the normal course of a medical practice. The additions allow for the use of those licensed in other states to function without the usual requirements for themselves and the physicians working with them.
The amendments to § 18.171 (relating to physician assistant identification) maintain the requirement that a PA wear an identification tag bearing the term ''physician assistant'' but would modify the requirement for it to be in 16 point or larger type to being an easily readable type. The typeface for 16 point is excessively large, particularly for individuals with lengthy or hyphenated names. Finally, the amendments render the regulations gender neutral.
E. Fiscal Impact and Paperwork Requirements
There is no adverse fiscal impact or paperwork requirement imposed on the Commonwealth, political subdivision or the private sector.
F. Sunset Date
The Board continuously monitors its regulations. Therefore, no sunset date has been assigned.
G. Regulatory Review
Under section 5(a) of the Regulatory Review Act (71 P. S. § 745.5(a)), on October 26, 2005, the Board submitted a copy of this proposed rulemaking and a copy of a Regulatory Analysis Form to the Independent Regulatory Review Commission (IRRC) and to the Chairpersons of the Senate Consumer Protection and Professional Licensure Committee and the House Professional Licensure Committee. A copy of this material is available to the public upon request.
Under section 5(g) of the Regulatory Review Act, IRRC may convey any comments, recommendations or objections to the proposed rulemaking within 30 days of the close of the public comment period. The comments, recommendations or objections must specify the regulatory review criteria which have not been met. The Regulatory Review Act specifies detailed procedures for review, prior to final publication of the rulemaking, by the Board, the General Assembly and the Governor of comments, recommendations or objections raised.
H. Public Comment
Interested persons are invited to submit written comments, recommendations or objections regarding the proposed rulemaking to Gerald S. Smith, Board Counsel, P. O. Box 2649, Harrisburg, PA 17105-2649 within 30 days following publication for the proposed rulemaking in the Pennsylvania Bulletin.
CHARLES D. HUMMER, Jr., M. D.,
ChairpersonFiscal Note: 16A-4916. No fiscal impact; (8) recommends adoption.
Annex A
TITLE 49. PROFESSIONAL AND VOCATIONAL STANDARDS
PART I. DEPARTMENT OF STATE
Subpart A. PROFESSIONAL AND OCCUPATIONAL AFFAIRS
CHAPTER 16. STATE BOARD OF MEDICINE-GENERAL PROVISIONS
Subchapter B. GENERAL LICENSE, CERTIFICATION AND REGISTRATION PROVISIONS § 16.11. Licenses, certificates and registrations.
* * * * * (b) The following nonmedical doctor licenses [and certificates] are issued by the Board:
* * * * * (2) Physician assistant [certificate] license.
(c) The following registrations are issued by the Board:
(1) Registration as a [physician assistant supervisor] supervising physician of a physician assistant.
* * * * * § 16.13. Licensure, certification, examination and registration fees.
* * * * * (c) Physician Assistant [Certificate] License
* * * * * Registration, [physician assistant supervisor] supervising physician $35
Registration of additional [supervisors] supervising physicians $5
* * * * *
CHAPTER 18. STATE BOARD OF MEDICINE--PRACTITIONERS OTHER THAN MEDICAL DOCTORS
Subchapter D. PHYSICIAN ASSISTANTS
GENERAL PROVISIONS § 18.121. Purpose.
This subchapter implements section 13 of the act (63 P. S. § 422.13) pertaining to physician assistants and provides for the delegation of certain medical tasks to qualified physician assistants by [physician assistant supervisors] supervising physicians when the delegation is consistent with the written agreement.
§ 18.122. Definitions.
The following words and terms, when used in this subchapter, have the following meanings, unless the context clearly indicates otherwise:
* * * * * [Direct supervision--The physical presence of the physician assistant supervisor on the premises so that the physician assistant supervisor is immediately available to the physician assistant when needed.]
* * * * * Drug--A term used to describe a [drug] medication, device or agent which a physician assistant prescribes or dispenses under § 18.158 (relating to prescribing and dispensing drugs, pharmaceutical aids and devices).
* * * * * Medical regimen--A therapeutic, corrective or diagnostic measure [ordered by a physician assistant supervisor which is required for the management of a specific condition and which is incorporated into the written agreement.] performed or ordered by a physician, or performed or ordered by a physician assistant acting within the physician assistant's scope of practice, and in accordance with the written agreement between the supervising physician and the physician assistant.
* * *
Order--An oral or written directive for a therapeutic, corrective or diagnostic measure, including a drug to be dispensed for onsite administration in a hospital, medical care facility or office setting.
* * * * * Physician assistant--An individual who is [certified] licensed as a physician assistant by the Board.
Physician assistant examination--An examination to test whether an individual has accumulated sufficient academic knowledge to qualify for [certification] licensure as a physician assistant. The Board recognizes the certifying examination of the NCCPA.
Physician assistant program--A program for the training and education of physician assistants which is [approved] recognized by the Board and accredited by the Committee on Allied Health Education and Accreditation (CAHEA), Commission For Accreditation of Allied Health Educational Programs (CAAHEP), Accreditation Review Commission (ARC-PA) or any successor agency.
[Physician assistant supervisor--A physician who is identified as a supervising physician of a physician assistant in the written agreement and is registered with the Board as such.]
* * * * * Primary [physician assistant supervisor] supervising physician--A [physician assistant supervisor] medical doctor who is registered with the Board and designated in the written agreement as having primary responsibility for directing and supervising the physician assistant.
Satellite location--A location, other than the primary place at which the [physician assistant supervisor] supervising physician provides medical services to patients, where a physician assistant provides medical services.
Substitute [physician assistant supervisor] supervising physician--A [physician assistant supervisor] supervising physician who is registered with the Board and designated in the written agreement as assuming primary responsibility for a physician assistant when the primary [physician assistant supervisor] supervising physician is unavailable.
Supervising physician--A physician who is identified in a written agreement as the physician who supervises a physician assistant.
Supervision--[The control and personal direction exercised by the physician assistant supervisor over the medical services provided by a physician assistant. Constant physical presence of the physician assistant supervisor is not required so long as the physician assistant supervisor and the physician assistant are, or can easily be, in contact with each other by radio, telephone or telecommunications. Supervision requires the availability of the physician assistant supervisor to the physician assistant.]
(i) Oversight and direction of, and responsibility for, the medical services rendered by a physician assistant. The constant physical presence of the supervising physician is not required so long as the supervising physician and the physician assistant are, or can be, easily in contact with each other by radio, telephone or other telecommunications device.
(ii) An appropriate degree of supervision includes:
[(i)] (A) * * *
[(ii)] (B) Immediate availability of the [physician assistant supervisor] supervising physician to the physician assistant for necessary consultations.
[(iii)](C) Personal and regular[--at least week- ly--] review by the [physician assistant supervisor] supervising physician of the patient records upon which entries are made by the physician assistant.
Written agreement--The agreement between the physician assistant and [physician assistant supervisor] supervising physician, which satisfies the requirements of § 18.142 (relating to written agreements).
PHYSICIAN ASSISTANT EDUCATIONAL PROGRAMS § 18.131. [Approved] Recognized educational pro- grams/standards.
(a) The Board [approves] recognizes physician assistant educational programs [developed] accredited by the [accreditation review committee for the physician assistant, and accredited by the] American Medical Association's Committee on Allied Health Education and Accreditation (CAHEA) [of the American Medical Association], Commission for Accreditation of Allied Health Education Programs (CAAHEP), Accreditation Review Commission (ARC-PA) or any successor organization. Information regarding approved programs may be obtained directly from CAHEA, 515 North State Street, Chicago, IL 60610. Information regarding approved programs may be obtained directly from ARC-PA at its website www.arc-pa.org.
(b) The criteria for [certification] recognition by the Board of physician assistant educational programs will be identical to the essentials developed by the various organizations listed in this section or other accrediting agencies approved by the Board.
[CERTIFICATION] LICENSURE OF PHYSICIAN ASSISTANTS AND REGISTRATION OF [PHYSICIAN ASSISTANT SUPERVISORS] SUPERVISING PHYSICIANS § 18.141. Criteria for [certification] licensure as a physician assistant.
The Board will approve for [certification] licensure as a physician assistant an applicant who:
(1) Satisfies the [certification] licensure requirements in § 16.12 (relating to general qualifications for licenses and certificates).
(2) Has graduated from a physician assistant program [approved] recognized by the Board.
* * * * * § 18.142. Written agreements.
(a) The written agreement required by section 13(e) of the act (63 P. S. § 422.13(e)) [shall satisfy] satifies the following requirements. The agreement [shall] must:
(1) Identify and be signed by the physician assistant and [each physician the physician assistant who will be assisting] each physician acting as a supervising physician. At least one physician shall be a medical doctor.
(2) Describe the manner in which the physician assistant [will be assisting each named physician] works with each supervising physician. The description [shall] must list functions to be delegated to the physician assistant[, including:
(i) Selected procedures enumerated in § 18.151 (relating to the role of the physician assistant) and other delegated tasks.
(ii) Instructions for the use of the physician assistant in performance of delegated tasks.
(iii) Medical regimens to be administered or relayed by the physician assistant].
* * * * * (4) Designate one of the named physicians who shall be a medical doctor as the primary [physician assistant supervisor] supervising physician.
(5) Require that the supervising physician shall countersign the patient record completed by the physician assistant within a reasonable amount of time. This time period may not exceed 10 days.
(6) Identify the locations and practice settings where the physician assistant will serve.
(b) The written agreement shall be approved by the Board [as satisfying the foregoing requirements in subsection (a) and as being consistent with relevant provisions of the act and regulations contained in this subchapter].
(c) A physician assistant or [physician assistant supervisor] supervising physician shall provide immediate access to the written agreement to anyone seeking to confirm the scope of the physician assistant's authority.
§ 18.143. Criteria for registration as [physician assistant supervisor] a supervising physician.
(a) The Board will [approve for registration as] register a [physician assistant supervisor an] supervising physician applicant who:
* * * * * (2) Has [submitted] filed a completed [application] registration form accompanied by the written agreement (see § 18.142 (relating to written agreements)) and the required fee under § 16.13 (relating to licensure, certification, examination and registration fees). The [application] registration requires detailed information regarding the physician's professional background and specialties, medical education, internship, residency, continuing education, membership in American Boards of medical specialty, hospital or staff privileges and other information the Board may require.
(3) Includes with the [application] registration, a list, identifying by name and license number, the other physicians who are serving as [physician assistant supervisors] supervising physicians of the designated physician assistant under other written agreements.
(b) If the [applicant] supervising physician plans to utilize physician assistants in satellite locations, the [applicant] supervising physician shall provide the Board with supplemental information as set forth in § 18.155 (relating to satellite locations) and additional information requested by the Board directly relating to the satellite location.
(c) The Board will keep a current [register of approved] list of registered supervising physicians. The [register] list will include the physician's name, the address of residence, current business address, the date of [approval] filing, satellite locations if applicable, the names of current physician assistants under [his] the physician's supervision and the physicians willing to provide substitute supervision.
§ 18.144. Responsibility of primary [physician assistant supervisor] supervising physician.
A primary [physician assistant supervisor] supervising physician shall assume the following responsibilities. The supervisor shall:
* * * * * (3) Arrange for a substitute [physician assistant supervisor] supervising physician. (See § 18.154 (relating to substitute [physician assistant supervisor] supervising physician.)
(4) [See each patient in his office every third visit, but at least once a year.] Review directly with the patient the progress of the patient's care as needed based upon the patient's medical condition and prognosis or as requested by the patient.
* * * * * (7) Accept full professional and legal responsibility for the performance of the physician assistant and the care and treatment of [his] the patients.
§ 18.145. Biennial registration requirements; renewal of physician assistant [certification] license.
* * * * * (b) The fee for the biennial registration of a physician assistant [certificate] license is set forth in § 16.13 (relating to licensure, certification, examination and registration fees).
(c) To be eligible for renewal of a physician assistant [certification] license, the physician assistant shall maintain [his] National certification by completing current recertification mechanisms available to the profession and recognized by the Board.
(d) The Board will keep a current [register] list of persons [certified] licensed as physician assistants. The [register] list will include:
* * * * * (4) The date of initial [certification] licensure, biennial renewal record and current [physician assistant supervisor] supervising physician.
PHYSICIAN ASSISTANT UTILIZATION § 18.151. Role of physician assistant.
[The physician assistant shall, under appropriate direction and supervision by a physician assistant supervisor, augment the physician's data gathering abilities in order to assist the physician in reaching decisions and instituting care plans for the physician's patients. Physician assistants may be permitted to perform the following functions. This list is not intended to be all-inclusive.
(1) Screen patients to determine need for medical attention.
(2) Review patient records to determine health status.
(3) Take a patient history.
(4) Perform a physical examination.
(5) Perform developmental screening examination on children.
(6) Record pertinent patient data.
(7) Make decisions regarding data gathering and appropriate management and treatment of patients being seen for the initial evaluation of a problem or the follow-up evaluation of a previously diagnosed and stabilized condition.
(8) Prepare patient summaries.
(9) Initiate requests for commonly performed initial laboratory studies.
(10) Collect specimens for and carry out commonly performed blood, urine and stool analyses and cultures.
(11) Identify normal and abnormal findings on history, physical examination and commonly performed laboratory studies.
(12) Initiate appropriate evaluation and emergency management for emergency situations, for example, cardiac arrest, respiratory distress, injuries, burns and hemorrhage.
(13) Perform clinical procedures such as:
(i) Venipuncture.
(ii) Intradermal tests.
(iii) Electrocardiogram.
(iv) Care and suturing of minor lacerations.
(v) Casting and splinting.
(vi) Control of external hemorrhage.
(vii) Application of dressings and bandages.
(viii) Administration of medications, except as specified in § 18.158 (relating to prescribing and dispensing drugs), intravenous fluids, whole blood and blood components except as specified in § 18.157 (relating to administration of controlled substances and whole blood and blood components).
(ix) Removal of superficial foreign bodies.
(x) Cardio-pulmonary resuscitation.
(xi) Audiometry screening.
(xii) Visual screening.
(xiii) Carrying out aseptic and isolation techniques.
(14) Provide counseling and instruction regarding common patient problems.]
(a) The physician assistant practices medicine with physician supervision. A physician assistant may perform those duties and responsibilities, including the ordering, prescribing, dispensing, and administration of drugs and medical devices, as well as the ordering, prescribing, and executing of diagnostic and therapeutic medical regimens, as directed by the supervising physician.
(b) The physician assistant may provide any medical service as directed by the supervising physician when the service is within the physician assistant's skills, forms a component of the physician's scope of practice, is included in the written agreement and is provided with the amount of supervision in keeping with the accepted standards of medical practice.
(c) The physician assistant may pronounce death, but not the cause of death, and may authenticate with his signature any form related to pronouncing death.
(d) The physician assistant may authenticate with his signature any form that may otherwise be authenticated by a physician's signature as permitted by the supervising physician, State or Federal law and facility protocol, if applicable.
(e) The physician assistant shall be considered the agent of the supervising physician in the performance of all practice-related activities including the ordering of diagnostic, therapeutic and other medical services.
§ 18.152. Prohibitions.
(a) A physician assistant may not:
* * * * * (3) Maintain or manage a satellite location under § 18.155 (relating to satellite locations) unless [approved by] the maintenance or management is registered with the Board.
(4) Independently practice or bill patients for services provided.
* * * * * (8) [Pronounce a patient dead.
(9)] Perform a medical service without the supervision of a [physician assistant supervisor] supervising physician.
(b) A [physician assistant supervisor] supervising physician may not:
* * * * * § 18.153. Executing and relaying medical regimens.
(a) A physician assistant may execute a written or oral order for a medical regimen or may relay a written or oral order for a medical regimen to be executed by a health care practitioner subject to the requirements of this section.
(b) [The] As provided for in the written agreement, the physician assistant shall report orally or in writing, to a [physician assistant supervisor] supervising physician, within [12] 36 hours, those medical regimens executed or relayed by [him] the physician assistant while the [physician assistant supervisor] supervising physician was not physically present, and the basis for each decision to execute or relay a medical regimen.
(c) The physician assistant shall record, date and authenticate the medical regimen on the patient's chart at the time it is executed or relayed. The [physician assistant supervisor] supervising physician shall countersign the patient's record within a reasonable time not to exceed [3] 10 days, unless countersignature is required sooner by regulation, policy within the medical care facility or the requirements of a third-party payor.
(d) A physician assistant or [physician assistant supervisor] supervising physician shall provide immediate access to the written agreement to anyone seeking to confirm the physician assistant's authority to relay a medical regimen or administer a therapeutic or diagnostic measure.
§ 18.154. Substitute [physician assistant supervisor] supervising physician.
(a) If the primary [physician assistant supervisor] supervising physician is unavailable to supervise the physician assistant, the primary [physician assistant supervisor] supervising physician may not delegate patient care to the physician assistant unless [he has made] appropriate arrangements for substitute supervision are in the written agreement and the substitute physician is registered as a [physician assistant supervisor] supervising physician with the Board.
(b) It is the responsibility of the substitute [physician assistant supervisor] supervising physician to ensure that supervision is maintained in the absence of the primary [physician assistant supervisor] supervising physician.
(c) During the period of supervision by the substitute [physician assistant supervisor] supervising physician, [he] the substitute supervising physician retains full professional and legal responsibility for the performance of the physician assistant and the care and treatment of the patients treated by the physician assistant.
(d) Failure to properly supervise may provide grounds for disciplinary action against the substitute [physician assistant supervisor] supervising physician.
§ 18.155. Satellite locations.
(a) [Approval] Registration of satellite location. A physician assistant may not provide medical services at a satellite location unless the supervising physician has [obtained specific approval from] filed a registration with the Board.
(b) [Separate application requirement] Contents of statement. A separate [application] statement shall be made for each satellite location. [To obtain approval for each satellite location a physician assistant supervisor shall] The statement must demonstrate that:
* * * * * (2) There is adequate provision for direct communication between the physician assistant and the [physician assistant supervisor] supervising physician and that the distance between the location where the physician provides services and the satellite location is not so great as to prohibit or impede appropriate support services.
(3) [The supervisor will see each patient every third visit, but at least once a year.] The supervising physician shall review directly with the patient the progress of the patient's care as needed based upon the patient's medical condition and prognosis or as requested by the patient.
(4) The [supervisor] supervising physician will visit the satellite location at least weekly and devote enough time onsite to provide supervision and personally review the records of [each patient] selected patients seen by the physician assistant in this setting. The supervising physician shall notate those patient records as reviewed.
(c) Failure to comply with this section. Failure to maintain the standards required for a satellite location may result not only in the loss of the privilege to maintain a satellite location but also may result in disciplinary action against the physician assistant and the [physician assistant supervisor] supervising physician.
§ 18.156. Monitoring and review of physician assistant utilization.
(a) Representatives of the Board will be authorized to conduct scheduled and unscheduled onsite inspections of the locations where the physician assistants are utilized during the [physician assistant supervisors'] supervising physician's office hours to review the following:
(1) Supervision of the physician assistant. See §§ 18.144 and 18.154 (relating to responsibility of primary [physician assistant supervisor] supervising physician; and substitute [physician assistant supervisor] supervising physician).
* * * * * (5) Compliance with [certification] licensure and registration requirements. See §§ 18.141 and 18.145 (relating to criteria for [certification] licensure as a physician assistant; and biennial registration requirements; renewal of physician assistant [certification] license).
(6) Maintenance of records evidencing patient and supervisory contact by the [physician assistant supervisor] supervising physician.
(b) Reports shall be submitted to the Board and become a permanent record under the [physician assistant supervisor's] supervising physician's registration. Deficiencies reported [shall] will be reviewed by the Board and may provide a basis for loss of the privilege to maintain a satellite location and disciplinary action against the physician assistant and the [physician assistant supervisor] supervising physician.
(c) The Board reserves the right to review physician assistant utilization without prior notice to either the physician assistant or the [physician assistant supervisor] supervising physician. It is a violation of this subchapter for a [physician assistant supervisor] supervising physician or a physician assistant to refuse to comply with the request by the Board for the information in subsection (a).
* * * * * § 18.157. Administration of controlled substances and whole blood and blood components.
(a) [The] In a hospital, medical care facility or office setting, the physician assistant may order or administer, or both order and administer, controlled substances and whole blood and blood components if the authority to order and administer these medications and fluids is expressly set forth in the written agreement [and the administration of these medications and fluids is separately ordered by the physician assistant supervisor and the physician assistant supervisor specifies a named drug for a named patient].
(b) The physician assistant shall comply with the minimum standards for ordering and administering controlled substances specified in § 16.92 (relating to prescribing, administering and dispensing controlled substances).
§ 18.158. Prescribing and dispensing drugs, pharmaceutical aids and devices.
(a) [The Board adopts the American Hospital Formulary Service (AHFS) Pharmacologic--Therapeutic Classification to identify drugs which a physician assistant may prescribe and dispense subject to the restrictions specified in subsection (c).
(1) Categories from which a physician assistant may prescribe and dispense without limitations are as follows:
(i) Antihistamines.
(ii) Anti-infective agents.
(iii) Cardiovascular drugs.
(iv) Contraceptives--for example, foams and devices.
(v) Diagnostic agents.
(vi) Disinfectants--for agents used on objects other than skin.
(vii) Electrolytic, caloric and water balance.
(viii) Enzymes.
(ix) Antitussives, expectorants, and nucolytic agents.
(x) Gastrointestianal drugs.
(xi) Local anesthetics.
(xii) Serums, toxoids and vaccines.
(xiii) Skin and mucous membrane agents.
(xiv) Smooth muscle relaxants.
(xv) Vitamins.
(2) Categories from which a physician assistant may prescribe and dispense subject to exclusions and limitations listed:
(i) Autonomic drugs. Drugs excluded under this category: Sympathomimetic (adrenergic) agents.
(ii) Blood formation and coagulation. Drugs excluded under this category:
(A) Anti-coagulants and coagulants.
(B) Thrombolytic agents.
(iii) Central nervous system agents. Drugs excluded under this category:
(A) General anesthetics.
(B) Monoamine oxidase inhibitors.
(iv) Eye, ear, nose and throat preparations. Drugs limited under this category: Miotics and mydriatrics used as eye preparations require specific approval from the physician assistant supervisor for a named patient.
(v) Hormones and synthetic substitutes. Drugs excluded under this category:
(A) Pituitary hormones and synthetics.
(B) Parathyroid hormones and synthetics.
(3) Categories from which a physician assistant may not prescribe or dispense are as follows:
(i) Antineoplastic agents.
(ii) Dental agents.
(iii) Gold compounds.
(iv) Heavy metal antagonists.
(v) Oxytocics.
(vi) Radioactive agents.
(vii) Unclassified therapeutic agents.
(viii) Devices.
(ix) Pharmaceutical aids.
(4) New drugs and new uses for drugs will be considered approved for prescribing and dispensing purposes by physician assistants 90 days after approval by the Federal Drug Administration unless excluded in paragraphs (2) and (3).
(b) If the physician assistant supervisor intends to authorize a physician assistant to prescribe or dispense drugs, the supervisor shall:
(1) Establish a list of drugs, based on the categories listed in subsection (a), which the physician assistant may prescribe or dispense. The physician assistant supervisor shall assure that the physician assistant is able to competently prescribe or dispense those drugs.
(2) Submit the list of drugs to the Board, in duplicate, on a form supplied by the Board, and signed by both physician assistant supervisor and the physician assistant. The list will become part of the physician assistant's written agreement if it is consistent with the approved classification.
(3) Notify the Board, in duplicate, on a form supplied by the Board, of an addition or deletion to the list of drugs. The amendment will become part of the physician assistant's written agreement if it is consistent with the approved classification.
(4) Assume full responsibility for every prescription issued and drug dispensed by a physician assistant under his supervision.
(5) Maintain a copy of the list of drugs submitted to the Board in his principal office and at all locations where the physician assistant practices under his supervision for review or inspection without prior notice by patients, the Board or its agents. The physician shall provide a pharmacy with a copy of the drug list upon request by the pharmacist.
(6) Immediately advise the patient, notify the physician assistant and, in the case of a written prescription, advise the pharmacy, if the physician assistant is prescribing or dispensing a drug inappropriately. The physician shall advise the patient and notify the physician assistant to discontinue using the drug, and in the case of a written prescription, shall notify the pharmacy to discontinue the prescription. The order to discontinue use of the drug or prescription shall be noted in the patient's medical record by the physician.
(c) Restrictions on a physician assistant's prescription and dispension practices are as follows:
(1) A physician assistant may only prescribe or dispense a drug approved by the Board from the categories specified in subsection (a).
(2) A physician assistant may only prescribe or dispense a drug for a patient who is under the care of the physician responsible for the supervision of the physician assistant and only in accordance with the physician's instructions and written agreement.
(3) A physician assistant shall comply with the minimum standards for prescribing and dispensing controlled substances specified in § 16.92 (relating to prescribing, administering and dispensing controlled substances) and the regulations of the Department of Health relating to Controlled Substances, Drugs, Devices and Cosmetics, 28 Pa. Code §§ 25.51--25.58 (relating to prescriptions), and packaging and labeling dispensed drugs. See §§ 16.93 and 16.94 (relating to packaging; and labeling of dispensed drugs) and 28 Pa. Code §§ 25.91--25.95 (relating to labeling of drugs, devices and cosmetics).
(4) A physician assistant may not:
(i) Prescribe or dispense a pure form or combination of drugs listed in subsection (a) unless the drug or class of drug is listed as permissible for prescription or dispension.
(ii) Prescribe or dispense Schedule I or II controlled substances as defined by section 4 of the Controlled Substances, Drug, Device, and Cosmetic Act (35 P. S. § 780-104).
(iii) Prescribe or dispense a drug for a use not permitted by the Food and Drug Administration.
(iv) Prescribe or dispense a generic or branded preparation of a drug that has not been approved by the Food and Drug Administration.
(v) Prescribe or dispense parenteral preparations other than insulin, emergency allergy kits and other approved drugs listed in subsection (a).
(vi) Dispense a drug unless it is packaged in accordance with applicable Federal and State law pertaining to packaging by physicians. See §§ 16.93 and 16.94.
(vii) Compound ingredients when dispensing a drug, except for adding water.
(viii) Issue a prescription for more than a 30-day supply, except in cases of chronic illnesses where a 90-day supply may be prescribed. The physician assistant may authorize refills up to 6 months from the date of the original prescription if not otherwise precluded by law.
(d) The requirements for prescription blanks are as follows:
(1) Prescription blanks shall bear the certification number of the physician assistant and the name of the physician assistant in printed format at the heading of the blank, and a space for the entry of the Drug Enforcement Administration registration number as appropriate. The physician assistant supervisor shall also be identified as required in § 16.91 (relating to identifying information on prescriptions and orders for equipment and service).
(2) The physician assistant supervisor is prohibited from presigning prescription blanks or allowing the physician assistant to use a device for affixing a signature copy on the prescription. The signature of a physician assistant shall be followed by the initials ''PA-C'' or similar designation to identify the signer as a physician assistant.
(3) The physician assistant may use a prescription blank generated by a hospital if the information in paragraph (1) appears on the blank.]
Prescribing, dispensing and administration of drugs.
(1) The supervising physician may delegate to the physician assistant the prescribing, dispensing and administering of drugs and therapeutic devices.
(2) A physician assistant may not prescribe or dispense Schedule I controlled substances as defined by section 4 of The Controlled Substances, Drug, Device, and Cosmetic Act (35 P. S. § 780-104).
(3) A physician assistant may prescribe a Schedule II controlled substance for initial therapy, up to a 72-hour dose. The physician assistant shall notify the supervising physician of the prescription as soon as possible but in no event longer than 24 hours from the issuance of the prescription. A physician assistant may write a prescription for a Schedule II controlled substance for up to a 30-day supply if it was originally prescribed by the supervising physician and approved by the supervising physician for ongoing therapy.
(4) A physician assistant may only prescribe or dispense a drug for a patient who is under the care of the physician responsible for the supervision of the physician assistant and only in accordance with the supervising physician's instructions and written agreement.
(5) A physician assistant may request, receive and sign for professional samples and may distribute professional samples to patients.
(6) A physician assistant authorized to prescribe or dispense, or both, controlled substances shall register with the Drug Enforcement Administration.
(b) Prescription blanks. The requirements for prescription blanks are as follows:
(1) Prescription blanks must bear the license number of the physician assistant and the name of the physician assistant in printed format at the heading of the blank. The supervising physician shall also be identified as required in § 16.91 (relating to identifying information on prescriptions and orders for equipment and service).
(2) The signature of a physician assistant shall be followed by the initials ''PA-C'' or similar designation to identify the signer as a physician assistant. When appropriate, the physician assistant's DEA registration number must appear on the prescription.
(3) The supervising physician is prohibited from presigning prescription blanks.
(4) The physician assistant may use a prescription blank generated by a hospital provided the information in paragraph (1) appears on the blank.
(c) Inappropriate prescription. The supervising physician shall immediately advise the patient, notify the physician assistant and, in the case of a written prescription, advise the pharmacy, if the physician assistant is prescribing or dispensing a drug inappropriately. The supervising physician shall advise the patient and notify the physician assistant to discontinue using the drug, and in the case of a written prescription, shall notify the pharmacy to discontinue the prescription. The order to discontinue use of the drug or prescription shall be noted in the patient's medical record by the supervising physician.
[(e)] (d) Recordkeeping requirements. Recordkeeping requirements are as follows:
* * * * * (2) When dispensing a drug, the physician assistant shall record [his] the physician assistant's name, the name of the medication dispensed, the amount of medication dispensed, the dose of the medication dispensed and the date dispensed in the patient's medical records.
(3) The physician assistant shall report, orally or in writing, to the [physician assistant supervisor] supervising physician within [12] 36 hours, a drug prescribed or medication dispensed by [him] the physician assistant while the [physician assistant supervisor] supervising physician was not physically present, and the basis for each decision to prescribe or dispense in accordance with the written agreement.
(4) [The physician assistant supervisor shall countersign the prescription copy or medical record entry for each prescription or dispension within a reasonable time, not to exceed 3 days, unless countersignature is required sooner by regulation, policy within the medical care facility or the requirements of a third-party payor.] The supervising physician shall countersign the patient record within 10 days.
(5) The physician assistant and the [physician assistant supervisor] supervising physician shall provide immediate access to the written agreement to anyone seeking to confirm the physician assistant's authority to prescribe or dispense a drug. The written agreement must list the categories of drugs which the physician assistant is not permitted to prescribe.
(e) Compliance with regulations relating to prescribing, administering, dispensing, packaging and labelling of drugs. A physician assistant shall comply with §§ 16.92, 16.93 and 16.94 (relating to prescribing, administering and dispensing controlled substances; packaging; and labeling of dispensed drugs) and Department of Health regulations in 28 Pa. Code §§ 25.51--25.58 (relating to prescriptions) and regulations regarding packaging and labeling dispensed drugs. See § 16.94 and 28 Pa. Code §§ 25.91--25.95 (relating to labeling of drugs, devices and cosmetics).
§ 18.159. Medical records.
The [physician assistant supervisor] supervising physician shall timely review the medical records prepared by the physician assistant to ensure that the requirements of § 16.95 (relating to medical records) have been satisfied.
MEDICAL CARE FACILITIES AND EMERGENCY MEDICAL SERVICES § 18.161. Physician assistant employed by medical care facilities.
* * * * * (b) [The physician assistant may not be responsible to more than three physician assistant supervisors in a medical care facility.
(c)] This subchapter does not require medical care facilities to employ physician assistants or to permit their utilization on their premises. Physician assistants are permitted to provide medical services to the hospitalized patients of their [physician assistant supervisor] supervising physician if the medical care facility permits it.
§ l8.162. Emergency medical services.
(a) A physician assistant may only provide medical service in an emergency medical care setting if the physician assistant has training in emergency medicine, functions within the purview of his written agreement and is under the [direct] supervision of the [physician assistant supervisor] supervising physician.
(b) A physician assistant licensed in this State or licensed or authorized to practice in any other state of the United States who is responding to a need for medical care created by a declared state of emergency or a state or local disaster (not to be defined as an emergency situation which occurs in the place of one's employment) may render care consistent with relevant standards of care.
IDENTIFICATION AND NOTICE RESPONSIBILITIES § 18.171. Physician assistant identification.
(a) A physician assistant may not render medical services to a patient until the patient or the patient's legal guardian has been informed that:
* * * * * (2) The physician assistant may perform the service required as the agent of the physician and only as directed by the [physician assistant supervisor] supervising physician.
* * * * * (b) It is the [physician assistant supervisor's] supervising physician's responsibility to be alert to patient complaints concerning the type or quality of services provided by the physician assistant.
(c) In the [physician assistant supervisor's] supervising physician's office and satellite locations, a notice plainly visible to patients shall be posted in a prominent place explaining that a ''physician assistant'' is authorized to assist a physician in the provision of medical care and services. The [physician assistant supervisor] supervising physician shall display [his] the registration to supervise in [his] the office. The physician assistant's [certificate] license shall be prominently displayed at any location at which [he] the physician assistant provides services. Duplicate [certificates] licenses may be obtained from the Board if required.
(d) The physician assistant shall wear an identification tag which uses the term ''Physician Assistant,'' in [16 point] easily readable type. The tag shall be conspicuously worn.
§ 18.172. Notification of changes in employment.
(a) The physician assistant is required to notify the Board, in writing, of a change in or termination of employment or a change in mailing address within 15 days. Failure to notify the Board in writing of a change in mailing address may result in failure to receive pertinent material distributed by the Board. The physician assistant shall provide the Board with [his] the new address of residence, address of employment and name of registered [physician assistant supervisor] supervising physician.
(b) The [physician assistant supervisor] supervising physician is required to notify the board, in writing, of a change or termination of [his] supervision of a physician assistant within 15 days.
(c) Failure to notify the Board of changes in employment or a termination in the physician/physician assistant relationship is a basis for disciplinary action against the physician's license, [physician assistant supervisor] supervising physician's registration and the physician assistant's [certificate] license.
DISCIPLINE § 18.181. Disciplinary and corrective measures.
(a) A physician assistant who engages in unprofessional conduct is subject to disciplinary action under section 41 of the act (63 P. S. § 422.41). Unprofessional conduct includes the following:
(1) Misrepresentation or concealment of a material fact in obtaining a [certificate] license or a reinstatement thereof.
* * * * * (7) Impersonation of a licensed physician or another [certified] licensed physician assistant.
* * * * * (10) Continuation of practice while the physician assistant's [certificate] license has expired, is not registered or is suspended or revoked.
* * * * * (12) The failure to notify the [physician assistant supervisor] supervising physician that the physician assistant has withdrawn care from a patient.
(b) The Board will order the emergency suspension of the [certificate] license of a physician assistant who presents an immediate and clear danger to the public health and safety, as required by section 40 of the act (63 P. S. § 422.40).
(c) The [certificate] license of a physician assistant shall automatically be suspended, under conditions in section 40 of the act.
(d) The Board may refuse, revoke or suspend a physician's [approval to supervise a physician assistant] registration as a supervising physician for engaging in any of the conduct proscribed of Board-regulated practitioners in section 41 of the act [(63 P. S. § 422.41)].
[Pa.B. Doc. No. 05-2023. Filed for public inspection November 4, 2005, 9:00 a.m.]
No part of the information on this site may be reproduced for profit or sold for profit.This material has been drawn directly from the official Pennsylvania Bulletin full text database. Due to the limitations of HTML or differences in display capabilities of different browsers, this version may differ slightly from the official printed version.
